A large observational study published in JAMA examined how AI-enabled “ambient documentation” systems, or AI scribes, affected clinician workflow in routine practice. The analysis reported small changes in electronic health record use and time spent on clinical documentation. While the findings suggest measurable operational impacts, the magnitude appears limited rather than transformative, reinforcing that benefits may depend on implementation and clinical context. The study’s real-world design focuses on how scribes perform outside tightly controlled pilot settings. For health systems and biotech-facing service partners, the key practical takeaway is that ambient AI documentation is unlikely to eliminate administrative burden in a single step. Instead, it likely needs workflow redesign, training, and endpoint-specific measurement to translate into usable efficiency gains. As regulators and payers increase interest in digital endpoints and documentation integrity, evidence from real-world settings becomes central to decisions about scaling scribe deployments.